![1]()
News
Most rheumatology drugs don’t increase COVID-19 hospitalization risk
June 4, 2020
“These results provide, for the first time, information about the outcome of COVID-19 in patients with rheumatic and musculoskeletal diseases.”
News
Newer anticoagulants linked to lower fracture risk in AFib
May 26, 2020
Direct oral anticoagulants were associated with lower osteoporosis fracture risk than warfarin in patients with atrial fibrillation.
News
COVID-19 vaccine won’t be a slam dunk
May 21, 2020
A key safety concern to watch for in the coming months is whether a vaccine candidate is able to sidestep the issue of antibody-dependent enhancement, said Dr. Mehrdad Matloubian.
![1]()
News
DOACs linked to lower fracture risk versus warfarin in AFib patients
May 20, 2020
The results suggest women may particularly benefit from DOAC use.
![1]()
News
TNF inhibitors may dampen COVID-19 severity
May 19, 2020
New findings from the COVID-19 Global Rheumatology Alliance Registry.
News
Advice on treating rheumatic diseases from a COVID-19 epicenter
May 13, 2020
Hospital for Special Surgery rheumatologists discuss their approach to caring for patients with rheumatic diseases within their practice during the COVID-19 pandemic.
![1]()
News
ACR gives guidance on rheumatic disease management during pandemic
May 12, 2020
When COVID-19 is suspected, rheumatic disease patients may continue their hydroxychloroquine but other rheumatic disease treatments may need to be stopped or held.
News
Societies offer advice on treating osteoporosis patients during pandemic
May 11, 2020
General and specific recommendations from leading bone health organizations shine a light on how to manage osteoporosis patients during the COVID-19 pandemic.
![1]()
News
Case series suggests biologics, JAK inhibitors safe during pandemic
May 1, 2020
Investigators saw no increase in hospitalizations versus the general population in New York City.
News
Hospitals update hydroxychloroquine protocols after FDA warning
April 29, 2020
Some hospitals changed their use of hydroxychloroquine for patients with COVID-19 long before the FDA’s recent warning about the drug’s risks.
